US Patent Issued to Sangamo Therapeutics on Dec. 16 for "Clinical parameters by expression of factor VIII" (California Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,632, issued on Dec. 16, was assigned to Sangamo Therapeutics Inc. (Richmond, Calif.).

"Clinical parameters by expression of factor VIII" was invented by Edward R. Conner (Brisbane, Calif.), Brigit E. Riley (Brisbane, Calif.) and Didier Rouy (Brisbane, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are constructs used for liver-specific expression of a transgene."

The patent was filed on Aug. 2, 2019, under Application No. 17/265,750.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G...